Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Conditions

• Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

Eligibility Criteria

Sex

FEMALE

Age

N/A - N/A

Healthy Volunteers

Not accepted

Interventions

• Electronic Health Record Review — OTHER
  Medical records reviewed
• Laboratory Biomarker Analysis — OTHER
  Correlative studies

Study Details

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Key Dates

Start date

Aug 6, 2021

Status verified

Feb 2026

Primary completion

Sep 29, 2026

Completion

Sep 29, 2026

Study Design

Enrollment

70 participants (estimated)

Arms

• Arm: Observational (medical record review)
  Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.

Primary Outcome Measure

Clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix [ Time Frame: through study completion, an average of 1 year ]

Locations (1)

Find similar trials in Houston, TX